/Companies

Curavit

Boston, US · Founded 2019 · 2 known investors

Find your way into Curavit

Sign up to see every warm intro you have to Curavit

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Curavit team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Curavit designs and executes decentralized clinical trials using technology to improve patient outcomes and trial efficiency for pharmaceutical and medical device companies.

Founders & leadership

Curavit was founded in 2019 by Joel Morse, Pam Diamond, and Dave Hanaman.

JMJoel Morse
Joel MorseFounder & CEOJoel Morse is founder and CEO of Curavit, which designs and executes decentralized clinical trials using technology to improve patient outcomes and trial efficiency. He has held executive roles in global healthcare operations and has experience starting ventures, raising venture financing, building and scaling teams, and managing complex organizations.
PDPam Diamond
Pam DiamondCo-founder & Chief Medical Officer
DHDave Hanaman
Dave HanamanCo-founder, President & Chief Commercial OfficerDave Hanaman co-founded Curavit, where he serves as president and chief commercial officer, and previously co-founded and led C3i, a healthcare technology services firm, through its sale to a Fortune Global 500 company. He holds a degree from UC Berkeley and served as a naval intelligence officer.

Board

JK
Jackie KentBoard director
RL
Rich LesterBoard director
NL
Nathanael LentzBoard directorGeneral Partner at Osage Venture Partners

Investors · 2

Funding

SEC filings, press & company announcements

$16.4M disclosed across 2 of 3 rounds · 2022

▶$11.4MraisedSep 2024 · 30 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jackie KentDirector
  • Rich LesterDirector
  • Joel MorseExecutive Officer, Director
  • Nathanael LentzDirector
  • David HanamanDirector
Offering amount
$11.6M
Amount sold
$11.4M
First sale
Sep 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 3

Companies working in the same space as Curavit.

In the news

Frequently asked questions

What does Curavit do?
Curavit designs and executes decentralized clinical trials using technology to improve patient outcomes and trial efficiency for pharmaceutical and medical device companies.
Who founded Curavit?
Curavit was founded by Joel Morse, Pam Diamond, Dave Hanaman in 2019.
Who are Curavit's investors?
Curavit's investors include Osage Venture Partners, Royal Street Ventures Management Company, Llc.
How much funding has Curavit raised?
Curavit has disclosed $16.4M raised across 2 of its 3 known rounds.
Where is Curavit headquartered?
Curavit is headquartered in Boston, US.